Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations - Wikidata - awgldk - TriplyDB

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

http://www.wikidata.org/entity/Q28076935

about

Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia.Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?Examining the Relationship between Trace Lithium in Drinking Water and the Rising Rates of Age-Adjusted Alzheimer's Disease Mortality in Texas.

P2860

Q39231042-B1AD922C-FCC7-45B7-8349-DCF03ABCC434 Q39287194-F080D465-BF08-4B84-997D-FAB2F56F1DCD Q47657930-E2A0164E-FF7C-469B-9892-E7C9C8399156

P2860

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

http://www.wikidata.org/entity/Q28076935

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

@ast

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

@en

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

@nl

type

label

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

@ast

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

@en

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

@nl

prefLabel

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

@ast

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

@en

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

@nl

P1433

Q28076935-57D637A4-1741-4747-BDDF-AFAD74E2D81C

P1476

Q28076935-E19E6B8F-4CF6-4A95-B323-E7A633BC31E6

P2093

Q28076935-90049A1E-607C-4018-82D6-53EEDC86C385

Q28076935-988AE4B8-EADD-4444-81B2-0BD9318AAE81

Q28076935-9898E044-C954-4040-B28B-384618068C60

P275

Q28076935-414B20BE-0457-4E63-843F-2D5C610F4BEB

P2860

Q28076935-00821B02-5833-4A82-9ABE-C2F2DF2718ED

Q28076935-10A637D1-DE12-44F7-86FA-BF67D642D0A4

Q28076935-10C36CAD-A4E3-4AD1-8999-68D4CC94D3D4

Q28076935-11DD754E-A600-4240-99E0-ED85C26A6D8E

Q28076935-16B3DCAF-EC09-4242-86A6-1A0778EE0025

Q28076935-17AD0301-EA93-4F76-94EF-9FA1CF17F4F9

Q28076935-20129711-6D32-411B-91A5-1452117F5BC2

Q28076935-238103E1-569F-48A1-B1AF-29B990B82352

Q28076935-25BAEA25-E05B-402C-B39E-05F7E5EB881E

Q28076935-28EBB259-B5D9-4542-8ACA-BC418B2AFD79

P304

Q28076935-27F92453-BB3F-4864-B6DB-184AFB7044AC

P31

Q28076935-004773F7-A695-43D9-A0C4-13A0E4C0BFC0

Q28076935-09EFFACA-DA06-4133-BB74-1CEA1AAB35AD

P3181

Q28076935-AFE60CF3-3A46-405D-B702-485B685DD778

P356

Q28076935-B05C6B29-CD10-4E34-B86C-979522B5A718

P407

Q28076935-D485052D-CEA9-4EE2-8768-D08CCC3B6321

P433

Q28076935-065EA792-6B85-47A9-8AC6-DCFC36BF00B4

P478

Q28076935-940D48BF-65B8-4F18-8532-07600D558C00

P50

Q28076935-976ED831-1972-45CF-9542-D4E366C04ED0

P577

Q28076935-C1EA5203-562D-4A1B-B1D7-F20D62E68AD4

Q28076935-D167AE5B-1749-4683-82AD-6BB73B9BECE6

P698

Q28076935-9A70BB35-094E-4A9D-AADB-351F837EE160

P921

Q28076935-366A815A-6FF8-4776-A0E2-E3368B00CEF2

Q28076935-99FAA11F-5963-4587-AD29-51F2F3BFF613

Q28076935-D9CE3CFA-AF6D-4157-BD29-7567D702778E

P932

Q28076935-FCD1CC0D-DB3C-4474-A9B9-B1C013548FA6

P3181

P356

S40268-016-0139-7

P1433

P1476

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations

@en

P2093

Gabriele Sani

http://www.w3.org/2001/XMLSchema#string

Giovanni Manfredi

http://www.w3.org/2001/XMLSchema#string

Roberto Brugnoli

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Clinical practice guidelines in psychiatry: more confusion than clarity? A critical review and recommendation of a unified guideline

Severe lithium toxicity with "normal" serum concentrations

Massive overdoses with sustained-release lithium carbonate preparations: pharmacokinetic model based on two case studies.

Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP

Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring.

Lithium and the kidney: an updated review.

Prophylaxis of bipolar disorder: how and who should we treat in the long term?

Therapeutic drug monitoring of psychotropic medications.

P304

293-302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2858867

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S40268-016-0139-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27770296

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

inorganic compound

biomedical investigative technique

P932

5114200

http://www.w3.org/2001/XMLSchema#string